カテゴリー： Market Monitor Global, 世界, 医療/バイオ

転移性がん治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Metastatic Cancer Treat Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5766）◆商品コード：MMG23JU5766
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：77
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Metastatic Cancer Treat Drug Market 調査レポートは次の情報を含め、グローバルにおけるの転移性がん治療薬市場規模と予測を収録しています。・世界の転移性がん治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の転移性がん治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の転移性がん治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「化学療法薬」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

転移性がん治療薬のグローバル主要企業は、Roche、 Merck、 Johnson and Johnson、 Eli Lilly、 Sun Pharmaceutical、 Bayer、 Gilead Sciences、 GlaxoSmithKline、 Novartis、 Pfizer、 AstraZenecaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、転移性がん治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の転移性がん治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の転移性がん治療薬市場：タイプ別市場シェア、2022年
・化学療法薬、標的療法薬

世界の転移性がん治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の転移性がん治療薬市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の転移性がん治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の転移性がん治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における転移性がん治療薬のグローバル売上、2018年-2023年
・主要企業における転移性がん治療薬のグローバル売上シェア、2022年
・主要企業における転移性がん治療薬のグローバル販売量、2018年-2023年
・主要企業における転移性がん治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Roche、 Merck、 Johnson and Johnson、 Eli Lilly、 Sun Pharmaceutical、 Bayer、 Gilead Sciences、 GlaxoSmithKline、 Novartis、 Pfizer、 AstraZeneca

*************************************************************

・調査・分析レポートの概要
転移性がん治療薬市場の定義
市場セグメント
世界の転移性がん治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の転移性がん治療薬市場規模
世界の転移性がん治療薬市場規模：2022年 VS 2029年
世界の転移性がん治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの転移性がん治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の転移性がん治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：化学療法薬、標的療法薬
転移性がん治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
転移性がん治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別転移性がん治療薬市場規模 2022年と2029年
地域別転移性がん治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Roche、 Merck、 Johnson and Johnson、 Eli Lilly、 Sun Pharmaceutical、 Bayer、 Gilead Sciences、 GlaxoSmithKline、 Novartis、 Pfizer、 AstraZeneca
...

This report aims to provide a comprehensive presentation of the global market for Metastatic Cancer Treat Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metastatic Cancer Treat Drug. This report contains market size and forecasts of Metastatic Cancer Treat Drug in global, including the following market information:
Global Metastatic Cancer Treat Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Metastatic Cancer Treat Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Metastatic Cancer Treat Drug companies in 2022 (%)
The global Metastatic Cancer Treat Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Chemotherapy Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Metastatic Cancer Treat Drug include Roche, Merck, Johnson and Johnson, Eli Lilly, Sun Pharmaceutical, Bayer, Gilead Sciences, GlaxoSmithKline and Novartis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Metastatic Cancer Treat Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Metastatic Cancer Treat Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Metastatic Cancer Treat Drug Market Segment Percentages, by Type, 2022 (%)
Chemotherapy Drugs
Targeted Therapy Drugs
Global Metastatic Cancer Treat Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Metastatic Cancer Treat Drug Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Other
Global Metastatic Cancer Treat Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Metastatic Cancer Treat Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Metastatic Cancer Treat Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Metastatic Cancer Treat Drug revenues share in global market, 2022 (%)
Key companies Metastatic Cancer Treat Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Metastatic Cancer Treat Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Merck
Johnson and Johnson
Eli Lilly
Sun Pharmaceutical
Bayer
Gilead Sciences
GlaxoSmithKline
Novartis
Pfizer
AstraZeneca
Outline of Major Chapters:
Chapter 1: Introduces the definition of Metastatic Cancer Treat Drug, market overview.
Chapter 2: Global Metastatic Cancer Treat Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Metastatic Cancer Treat Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Metastatic Cancer Treat Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Metastatic Cancer Treat Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Metastatic Cancer Treat Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Metastatic Cancer Treat Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Metastatic Cancer Treat Drug Overall Market Size
2.1 Global Metastatic Cancer Treat Drug Market Size: 2022 VS 2029
2.2 Global Metastatic Cancer Treat Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Metastatic Cancer Treat Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Metastatic Cancer Treat Drug Players in Global Market
3.2 Top Global Metastatic Cancer Treat Drug Companies Ranked by Revenue
3.3 Global Metastatic Cancer Treat Drug Revenue by Companies
3.4 Global Metastatic Cancer Treat Drug Sales by Companies
3.5 Global Metastatic Cancer Treat Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Metastatic Cancer Treat Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Metastatic Cancer Treat Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Metastatic Cancer Treat Drug Players in Global Market
3.8.1 List of Global Tier 1 Metastatic Cancer Treat Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Metastatic Cancer Treat Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Metastatic Cancer Treat Drug Market Size Markets, 2022 & 2029
4.1.2 Chemotherapy Drugs
4.1.3 Targeted Therapy Drugs
4.2 By Type – Global Metastatic Cancer Treat Drug Revenue & Forecasts
4.2.1 By Type – Global Metastatic Cancer Treat Drug Revenue, 2018-2023
4.2.2 By Type – Global Metastatic Cancer Treat Drug Revenue, 2024-2029
4.2.3 By Type – Global Metastatic Cancer Treat Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Metastatic Cancer Treat Drug Sales & Forecasts
4.3.1 By Type – Global Metastatic Cancer Treat Drug Sales, 2018-2023
4.3.2 By Type – Global Metastatic Cancer Treat Drug Sales, 2024-2029
4.3.3 By Type – Global Metastatic Cancer Treat Drug Sales Market Share, 2018-2029
4.4 By Type – Global Metastatic Cancer Treat Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Metastatic Cancer Treat Drug Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Other
5.2 By Application – Global Metastatic Cancer Treat Drug Revenue & Forecasts
5.2.1 By Application – Global Metastatic Cancer Treat Drug Revenue, 2018-2023
5.2.2 By Application – Global Metastatic Cancer Treat Drug Revenue, 2024-2029
5.2.3 By Application – Global Metastatic Cancer Treat Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Metastatic Cancer Treat Drug Sales & Forecasts
5.3.1 By Application – Global Metastatic Cancer Treat Drug Sales, 2018-2023
5.3.2 By Application – Global Metastatic Cancer Treat Drug Sales, 2024-2029
5.3.3 By Application – Global Metastatic Cancer Treat Drug Sales Market Share, 2018-2029
5.4 By Application – Global Metastatic Cancer Treat Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Metastatic Cancer Treat Drug Market Size, 2022 & 2029
6.2 By Region – Global Metastatic Cancer Treat Drug Revenue & Forecasts
6.2.1 By Region – Global Metastatic Cancer Treat Drug Revenue, 2018-2023
6.2.2 By Region – Global Metastatic Cancer Treat Drug Revenue, 2024-2029
6.2.3 By Region – Global Metastatic Cancer Treat Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Metastatic Cancer Treat Drug Sales & Forecasts
6.3.1 By Region – Global Metastatic Cancer Treat Drug Sales, 2018-2023
6.3.2 By Region – Global Metastatic Cancer Treat Drug Sales, 2024-2029
6.3.3 By Region – Global Metastatic Cancer Treat Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Metastatic Cancer Treat Drug Revenue, 2018-2029
6.4.2 By Country – North America Metastatic Cancer Treat Drug Sales, 2018-2029
6.4.3 US Metastatic Cancer Treat Drug Market Size, 2018-2029
6.4.4 Canada Metastatic Cancer Treat Drug Market Size, 2018-2029
6.4.5 Mexico Metastatic Cancer Treat Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Metastatic Cancer Treat Drug Revenue, 2018-2029
6.5.2 By Country – Europe Metastatic Cancer Treat Drug Sales, 2018-2029
6.5.3 Germany Metastatic Cancer Treat Drug Market Size, 2018-2029
6.5.4 France Metastatic Cancer Treat Drug Market Size, 2018-2029
6.5.5 U.K. Metastatic Cancer Treat Drug Market Size, 2018-2029
6.5.6 Italy Metastatic Cancer Treat Drug Market Size, 2018-2029
6.5.7 Russia Metastatic Cancer Treat Drug Market Size, 2018-2029
6.5.8 Nordic Countries Metastatic Cancer Treat Drug Market Size, 2018-2029
6.5.9 Benelux Metastatic Cancer Treat Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Metastatic Cancer Treat Drug Revenue, 2018-2029
6.6.2 By Region – Asia Metastatic Cancer Treat Drug Sales, 2018-2029
6.6.3 China Metastatic Cancer Treat Drug Market Size, 2018-2029
6.6.4 Japan Metastatic Cancer Treat Drug Market Size, 2018-2029
6.6.5 South Korea Metastatic Cancer Treat Drug Market Size, 2018-2029
6.6.6 Southeast Asia Metastatic Cancer Treat Drug Market Size, 2018-2029
6.6.7 India Metastatic Cancer Treat Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Metastatic Cancer Treat Drug Revenue, 2018-2029
6.7.2 By Country – South America Metastatic Cancer Treat Drug Sales, 2018-2029
6.7.3 Brazil Metastatic Cancer Treat Drug Market Size, 2018-2029
6.7.4 Argentina Metastatic Cancer Treat Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Metastatic Cancer Treat Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Metastatic Cancer Treat Drug Sales, 2018-2029
6.8.3 Turkey Metastatic Cancer Treat Drug Market Size, 2018-2029
6.8.4 Israel Metastatic Cancer Treat Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Metastatic Cancer Treat Drug Market Size, 2018-2029
6.8.6 UAE Metastatic Cancer Treat Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Metastatic Cancer Treat Drug Major Product Offerings
7.1.4 Roche Metastatic Cancer Treat Drug Sales and Revenue in Global (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Metastatic Cancer Treat Drug Major Product Offerings
7.2.4 Merck Metastatic Cancer Treat Drug Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Johnson and Johnson
7.3.1 Johnson and Johnson Company Summary
7.3.2 Johnson and Johnson Business Overview
7.3.3 Johnson and Johnson Metastatic Cancer Treat Drug Major Product Offerings
7.3.4 Johnson and Johnson Metastatic Cancer Treat Drug Sales and Revenue in Global (2018-2023)
7.3.5 Johnson and Johnson Key News & Latest Developments
7.4 Eli Lilly
7.4.1 Eli Lilly Company Summary
7.4.2 Eli Lilly Business Overview
7.4.3 Eli Lilly Metastatic Cancer Treat Drug Major Product Offerings
7.4.4 Eli Lilly Metastatic Cancer Treat Drug Sales and Revenue in Global (2018-2023)
7.4.5 Eli Lilly Key News & Latest Developments
7.5 Sun Pharmaceutical
7.5.1 Sun Pharmaceutical Company Summary
7.5.2 Sun Pharmaceutical Business Overview
7.5.3 Sun Pharmaceutical Metastatic Cancer Treat Drug Major Product Offerings
7.5.4 Sun Pharmaceutical Metastatic Cancer Treat Drug Sales and Revenue in Global (2018-2023)
7.5.5 Sun Pharmaceutical Key News & Latest Developments
7.6 Bayer
7.6.1 Bayer Company Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer Metastatic Cancer Treat Drug Major Product Offerings
7.6.4 Bayer Metastatic Cancer Treat Drug Sales and Revenue in Global (2018-2023)
7.6.5 Bayer Key News & Latest Developments
7.7 Gilead Sciences
7.7.1 Gilead Sciences Company Summary
7.7.2 Gilead Sciences Business Overview
7.7.3 Gilead Sciences Metastatic Cancer Treat Drug Major Product Offerings
7.7.4 Gilead Sciences Metastatic Cancer Treat Drug Sales and Revenue in Global (2018-2023)
7.7.5 Gilead Sciences Key News & Latest Developments
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Company Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Metastatic Cancer Treat Drug Major Product Offerings
7.8.4 GlaxoSmithKline Metastatic Cancer Treat Drug Sales and Revenue in Global (2018-2023)
7.8.5 GlaxoSmithKline Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Metastatic Cancer Treat Drug Major Product Offerings
7.9.4 Novartis Metastatic Cancer Treat Drug Sales and Revenue in Global (2018-2023)
7.9.5 Novartis Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Metastatic Cancer Treat Drug Major Product Offerings
7.10.4 Pfizer Metastatic Cancer Treat Drug Sales and Revenue in Global (2018-2023)
7.10.5 Pfizer Key News & Latest Developments
7.11 AstraZeneca
7.11.1 AstraZeneca Company Summary
7.11.2 AstraZeneca Metastatic Cancer Treat Drug Business Overview
7.11.3 AstraZeneca Metastatic Cancer Treat Drug Major Product Offerings
7.11.4 AstraZeneca Metastatic Cancer Treat Drug Sales and Revenue in Global (2018-2023)
7.11.5 AstraZeneca Key News & Latest Developments
8 Global Metastatic Cancer Treat Drug Production Capacity, Analysis
8.1 Global Metastatic Cancer Treat Drug Production Capacity, 2018-2029
8.2 Metastatic Cancer Treat Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Metastatic Cancer Treat Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Metastatic Cancer Treat Drug Supply Chain Analysis
10.1 Metastatic Cancer Treat Drug Industry Value Chain
10.2 Metastatic Cancer Treat Drug Upstream Market
10.3 Metastatic Cancer Treat Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Metastatic Cancer Treat Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Metastatic Cancer Treat Drug in Global Market
Table 2. Top Metastatic Cancer Treat Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Metastatic Cancer Treat Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Metastatic Cancer Treat Drug Revenue Share by Companies, 2018-2023
Table 5. Global Metastatic Cancer Treat Drug Sales by Companies, (K Units), 2018-2023
Table 6. Global Metastatic Cancer Treat Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Metastatic Cancer Treat Drug Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Metastatic Cancer Treat Drug Product Type
Table 9. List of Global Tier 1 Metastatic Cancer Treat Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Metastatic Cancer Treat Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Metastatic Cancer Treat Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Metastatic Cancer Treat Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Metastatic Cancer Treat Drug Sales (K Units), 2018-2023
Table 15. By Type - Global Metastatic Cancer Treat Drug Sales (K Units), 2024-2029
Table 16. By Application – Global Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Metastatic Cancer Treat Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Metastatic Cancer Treat Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Metastatic Cancer Treat Drug Sales (K Units), 2018-2023
Table 20. By Application - Global Metastatic Cancer Treat Drug Sales (K Units), 2024-2029
Table 21. By Region – Global Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Metastatic Cancer Treat Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Metastatic Cancer Treat Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Metastatic Cancer Treat Drug Sales (K Units), 2018-2023
Table 25. By Region - Global Metastatic Cancer Treat Drug Sales (K Units), 2024-2029
Table 26. By Country - North America Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Metastatic Cancer Treat Drug Sales, (K Units), 2018-2023
Table 29. By Country - North America Metastatic Cancer Treat Drug Sales, (K Units), 2024-2029
Table 30. By Country - Europe Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Metastatic Cancer Treat Drug Sales, (K Units), 2018-2023
Table 33. By Country - Europe Metastatic Cancer Treat Drug Sales, (K Units), 2024-2029
Table 34. By Region - Asia Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Metastatic Cancer Treat Drug Sales, (K Units), 2018-2023
Table 37. By Region - Asia Metastatic Cancer Treat Drug Sales, (K Units), 2024-2029
Table 38. By Country - South America Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Metastatic Cancer Treat Drug Sales, (K Units), 2018-2023
Table 41. By Country - South America Metastatic Cancer Treat Drug Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Metastatic Cancer Treat Drug Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Metastatic Cancer Treat Drug Sales, (K Units), 2024-2029
Table 46. Roche Company Summary
Table 47. Roche Metastatic Cancer Treat Drug Product Offerings
Table 48. Roche Metastatic Cancer Treat Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Roche Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Metastatic Cancer Treat Drug Product Offerings
Table 52. Merck Metastatic Cancer Treat Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Johnson and Johnson Company Summary
Table 55. Johnson and Johnson Metastatic Cancer Treat Drug Product Offerings
Table 56. Johnson and Johnson Metastatic Cancer Treat Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Johnson and Johnson Key News & Latest Developments
Table 58. Eli Lilly Company Summary
Table 59. Eli Lilly Metastatic Cancer Treat Drug Product Offerings
Table 60. Eli Lilly Metastatic Cancer Treat Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Eli Lilly Key News & Latest Developments
Table 62. Sun Pharmaceutical Company Summary
Table 63. Sun Pharmaceutical Metastatic Cancer Treat Drug Product Offerings
Table 64. Sun Pharmaceutical Metastatic Cancer Treat Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Sun Pharmaceutical Key News & Latest Developments
Table 66. Bayer Company Summary
Table 67. Bayer Metastatic Cancer Treat Drug Product Offerings
Table 68. Bayer Metastatic Cancer Treat Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Bayer Key News & Latest Developments
Table 70. Gilead Sciences Company Summary
Table 71. Gilead Sciences Metastatic Cancer Treat Drug Product Offerings
Table 72. Gilead Sciences Metastatic Cancer Treat Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Gilead Sciences Key News & Latest Developments
Table 74. GlaxoSmithKline Company Summary
Table 75. GlaxoSmithKline Metastatic Cancer Treat Drug Product Offerings
Table 76. GlaxoSmithKline Metastatic Cancer Treat Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. GlaxoSmithKline Key News & Latest Developments
Table 78. Novartis Company Summary
Table 79. Novartis Metastatic Cancer Treat Drug Product Offerings
Table 80. Novartis Metastatic Cancer Treat Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Novartis Key News & Latest Developments
Table 82. Pfizer Company Summary
Table 83. Pfizer Metastatic Cancer Treat Drug Product Offerings
Table 84. Pfizer Metastatic Cancer Treat Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Pfizer Key News & Latest Developments
Table 86. AstraZeneca Company Summary
Table 87. AstraZeneca Metastatic Cancer Treat Drug Product Offerings
Table 88. AstraZeneca Metastatic Cancer Treat Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. AstraZeneca Key News & Latest Developments
Table 90. Metastatic Cancer Treat Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 91. Global Metastatic Cancer Treat Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Metastatic Cancer Treat Drug Production by Region, 2018-2023 (K Units)
Table 93. Global Metastatic Cancer Treat Drug Production by Region, 2024-2029 (K Units)
Table 94. Metastatic Cancer Treat Drug Market Opportunities & Trends in Global Market
Table 95. Metastatic Cancer Treat Drug Market Drivers in Global Market
Table 96. Metastatic Cancer Treat Drug Market Restraints in Global Market
Table 97. Metastatic Cancer Treat Drug Raw Materials
Table 98. Metastatic Cancer Treat Drug Raw Materials Suppliers in Global Market
Table 99. Typical Metastatic Cancer Treat Drug Downstream
Table 100. Metastatic Cancer Treat Drug Downstream Clients in Global Market
Table 101. Metastatic Cancer Treat Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Metastatic Cancer Treat Drug Segment by Type in 2022
Figure 2. Metastatic Cancer Treat Drug Segment by Application in 2022
Figure 3. Global Metastatic Cancer Treat Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Metastatic Cancer Treat Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Metastatic Cancer Treat Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Metastatic Cancer Treat Drug Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Metastatic Cancer Treat Drug Revenue in 2022
Figure 9. By Type - Global Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Metastatic Cancer Treat Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Metastatic Cancer Treat Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Metastatic Cancer Treat Drug Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Metastatic Cancer Treat Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Metastatic Cancer Treat Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Metastatic Cancer Treat Drug Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Metastatic Cancer Treat Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Metastatic Cancer Treat Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Metastatic Cancer Treat Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Metastatic Cancer Treat Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Metastatic Cancer Treat Drug Sales Market Share, 2018-2029
Figure 23. US Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Metastatic Cancer Treat Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Metastatic Cancer Treat Drug Sales Market Share, 2018-2029
Figure 28. Germany Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Metastatic Cancer Treat Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Metastatic Cancer Treat Drug Sales Market Share, 2018-2029
Figure 37. China Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Metastatic Cancer Treat Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Metastatic Cancer Treat Drug Sales Market Share, 2018-2029
Figure 44. Brazil Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Metastatic Cancer Treat Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Metastatic Cancer Treat Drug Sales Market Share, 2018-2029
Figure 48. Turkey Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Metastatic Cancer Treat Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Metastatic Cancer Treat Drug Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Metastatic Cancer Treat Drug by Region, 2022 VS 2029
Figure 54. Metastatic Cancer Treat Drug Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 転移性がん治療薬の世界市場見通し2023年-2029年(Metastatic Cancer Treat Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 膀胱がん標的薬の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆